MOS · 8-K · 20261103PR000139
Mosaic Biosciences Product Development
MOSAIC CO · 2026-11-03 · Importance 81 · Surprise 82 · No source text
Mosaic Biosciences year-to-date net sales doubled compared with the first nine months of 2025, supported in part by the launch of six new products. The company expected to launch up to four additional products in the fourth quarter. It said full-year net sales remained on track to double in 2026 to $135 million. The release defines new products as new brands or existing brands launched in new geographies.
Key facts
- Mosaic Biosciences full-year 2026 net sales remain on track to double, reaching $135 million. source
- Mosaic Biosciences year-to-date net sales doubled compared with the first nine months of 2025, supported in part by launching six new products. source
- Mosaic expects to launch up to four new Mosaic Biosciences products in Q4 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +2.0% | Mosaic Biosciences full-year 2026 net sales remain on track to double, reaching $135 million. |
| revenue | positive | realized | — | Mosaic Biosciences year-to-date net sales doubled compared with the first nine months of 2025, supported in part by launching six new… |
| revenue | positive | probable | — | Mosaic expects to launch up to four new Mosaic Biosciences products in Q4 2026. |